🇺🇸 FDA
Patent

US 11786598

Lipid formulations for delivery of therapeutic agents

granted A61KA61K31/713A61K47/44

Quick answer

US patent 11786598 (Lipid formulations for delivery of therapeutic agents) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/713, A61K47/44, A61K47/543, A61K9/0019